FDA.reportPublic FDA data

paliperidone palmitate 351 MG per 2.25 ML Extended Release Injectable Suspension in a Prefilled Syringe

RxCUI
2699342
RxNorm name
paliperidone palmitate 351 MG per 2.25 ML Extended Release Injectable Suspension in a Prefilled Syringe
Display name
paliperidone palmitate 351 MG per 2.25 ML Extended Release Injectable Suspension in a Prefilled Syringe
Full name
paliperidone palmitate 351 MG per 2.25 ML Extended Release Injectable Suspension in a Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Erzofri extended-releasePALIPERIDONE PALMITATEShandong Luye Pharmaceutical Co., Ltd.492bf9dd-868e-421a-92db-8cca8973aac12026-03-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2699342

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
492bf9dd-868e-421a-92db-8cca8973aac1paliperidone palmitate 351 MG per 2.25 ML Extended Release Injectable Suspension in a Prefilled SyringeSY7These highlights do not include all the information needed to use ERZOFRI ® safely and effectively. See full prescribing information for ERZOFRI ® . ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200620260309
492bf9dd-868e-421a-92db-8cca8973aac12.25 ML paliperidone palmitate 156 MG/ML Prefilled SyringeSCD7These highlights do not include all the information needed to use ERZOFRI ® safely and effectively. See full prescribing information for ERZOFRI ® . ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200620260309
492bf9dd-868e-421a-92db-8cca8973aac1paliperidone palmitate 351 MG per 2.25 ML Prefilled SyringeSY7These highlights do not include all the information needed to use ERZOFRI ® safely and effectively. See full prescribing information for ERZOFRI ® . ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200620260309
492bf9dd-868e-421a-92db-8cca8973aac1paliperidone palmitate 351 MG in 2.25 ML Prefilled SyringePSN7These highlights do not include all the information needed to use ERZOFRI ® safely and effectively. See full prescribing information for ERZOFRI ® . ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200620260309